Evidence map›Paper›PMID 27614097›Full record

Trial reportAddiction (Abingdon, England)2017

Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial.

Dorothy K Hatsukami, Xianghua Luo, Laura Dick, Margarita Kangkum, Sharon S Allen, Sharon E Murphy, Stephen S Hecht, Peter G Shields, Mustafa al'Absi

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Addiction (Abingdon, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02000921 (Models for Tobacco Productive Evaluation), which is not on this map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02000921 nacompletednot on this map

Models for Tobacco Productive Evaluation: Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors

TypeinterventionalSponsorUniversity of MinnesotaRan2013 to 2016Enrolled136ConditionsTobacco Addiction, Dual Tobacco UseArmsVLNC cigarettes, Combusted Products, Non-combusted products, CN cigarettes
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Regulatory Approaches and Implementation of Minimally Addictive Combusted Products.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Pooled it
  3. Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Manipulation of Menthol and Nicotine Content in Cigarettes: Effects on Smoking Behavior and Toxicant Exposure in Women Menthol Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Effect on Tobacco Use and Subjective Measures of Including E-cigarettes in a Simulated Ban of Menthol in Combustible Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Trial
  13. Trial
  14. Switching to Progressively Reduced Nicotine Content Cigarettes in Smokers With Low Socioeconomic Status: A Double-Blind Randomized Clinical Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dorothy K HatsukamiMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Xianghua LuoMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Laura DickMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Margarita KangkumMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Sharon S AllenFamily Medicine and Community Health, University of Minnesota, Minneapolis, MN, USA.
Sharon E MurphyMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Stephen S HechtMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Peter G ShieldsJames Cancer Center, Ohio State University, Columbus, OH, USA.
Mustafa al'AbsiDuluth Medical Research Institute, University of Minnesota Medical School, Duluth, MN, USA.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
Tobacco Constituent and Biomarker Assessment CoreU19CA157345 · NCI · UNIVERSITY OF MINNESOTA · PI HATSUKAMI, DOROTHY K, SHIELDS, PETER G. · 2012 to 2016
$13.3M
NCI NIH HHS P30 CA077598NCI NIH HHS U19 CA157345
6 · The paper itself

Abstract

aimsTo compare the use of alternative nicotine products, smoking behavior and tobacco biomarker exposure in smokers unwilling to quit who were assigned randomly to normal nicotine content (NNC) cigarettes or very low nicotine content (VLNC) cigarettes.

designRandomized, parallel-arm 8-week study with assignment to VLNC (VLNC 1, n = 53) or NNC (NNC, n = 27) with access to non-cigarette combusted and non-combusted tobacco/nicotine products or to VLNC with access to only non-combusted products (VLNC2, n = 56).

settingClinics in Minnesota, USA.

participantsSmokers uninterested in quitting smoking with a mean [± standard deviation (SD)] age of 44 (± 14) years and smoking 16 (± seven) cigarettes/day; 51% female, 72% white. MEASUREMENTS: During the experimental period, the measures taken included: rate of alternative products used, amount of and abstinence from combusted tobacco used and tobacco exposure biomarkers.

findingsThere were higher rates of non-combusted alternative tobacco/nicotine product use in both VLNC conditions versus the NNC condition [rate ratio (RR) = 2.18, 95% confidence interval (CI) = 1.94, 2.46 and RR = 1.64, 95% CI = 1.46, 1.85, respectively] and in VLNC1 versus VLNC2 condition (RR = 1.33, 95% CI = 1.23, 1.44), accompanied by reduced biomarkers of exposure primarily in VLNC2 condition compared to NNC condition (Ps < 0.05). Fewer combusted products were smoked at almost all visits (Ps ≤ 0.02) and there were higher rates of abstinence for both VLNC conditions compared with the NNC condition (VLNC1 versus NNC: RR = 9.96, 95% CI = 5.01, 19.81; VLNC2 versus NNC: RR = 11.23, 95% CI = 5.74, 21.97).

conclusionThe offer of, and instructions to use, reduced nicotine content cigarettes during an 8-week period led to greater use of alternative tobacco/nicotine products compared with continued use of normal nicotine cigarettes and also reductions in smoking rates.

Indexed as

AdultBiomarkersCigarette SmokingFemaleHumansMaleMiddle AgedNicotineTobacco ProductsTobacco Use Cessation DevicesBiomarkersNicotineAlternative nicotine delivery systemselectronic cigarettesexposure biomarkersmedicinal nicotinenicotine regulationproduct standardsreduced nicotine content cigarettessmokeless tobacco

Identifiers

PMID27614097
PMCPMC5249662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.